WVEHealthcareSmall-Cap

Wave Life Sciences Ltd. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Wave Life Sciences Ltd. (WVE), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are WVE insiders buying or selling?

Wave Life Sciences Ltd. insiders reported 8 open-market buys ($133.8M) and 70 sells ($29.6M) across 78 Form 4 filings — a net buying position of $104.2M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 31, 2026)

Total Form 4 filings
78
SEC EDGAR
Insider filers
14
Insider buys (8)
$133.8M
Insider sells (70)
$29.6M

Insider sentiment

Net buying

Net insider flow of $104.2M in net buying.

Recent WVE insider transactions

DateInsiderRoleTypeSharesPriceValue
Mar 31, 2026Peter KolchinskyDirector, 10% OwnerPurchase8.8M$6.23$54.6M
Feb 28, 2026Chris FrancisSVP, Corporate Development, Head of Emerging AreasSale33.2K$15.05$499.6K
Feb 12, 2026Kyle MoranChief Financial OfficerSale3.6K$13.45$48.3K
Feb 12, 2026Paul BolnoPresident and CEOSale10.5K$13.45$141.0K
Feb 12, 2026Chris FrancisSVP, Corporate Development, Head of Emerging AreasSale1.9K$13.45$25.3K
Feb 12, 2026Chandra VargeeseChief Technology Officer, Head of Platform Discovery SciencesSale3.2K$13.45$43.4K
Jan 7, 2026Chris FrancisSVP, Corporate Development, Head of Emerging AreasSale9.4K$16.03$150.3K
Nov 15, 2025Adrian RawcliffeDirectorSale16.1K$6.79$109.4K
Nov 14, 2025Peter KolchinskyDirector, 10% OwnerPurchase1.0K$6.69$6.7K
Aug 27, 2025Gregory L. VerdineDirectorSale10.0K$10.00$100.0K
Aug 27, 2025Paul BolnoPresident and CEOSale217.4K$10.10$2.2M
Aug 20, 2025Aik Na TanDirectorSale21.0K$9.25$194.3K
Aug 14, 2025Christian O HenryDirectorSale9.7K$8.81$85.2K
Aug 8, 2025Ken TakanashiDirectorSale4.9K$8.75$42.6K
Aug 8, 2025Aik Na TanDirectorSale1.1K$8.75$9.9K
Jun 14, 2025Gregory L. VerdineDirectorSale30.0K$6.95$208.5K
Mar 22, 2025Christian O HenryDirectorSale10.5K$9.77$102.6K
Mar 8, 2025Paul BolnoPresident and CEOSale169.0K$9.57$1.6M
Nov 28, 2024Paul BolnoPresident and CEOSale50.0K$15.00$750.0K
Nov 16, 2024Paul BolnoPresident and CEOSale51.2K$14.32$733.7K
Nov 14, 2024Chris FrancisSVP, Corporate Development, Head of Emerging AreasSale36.0K$16.00$576.0K
Oct 19, 2024Chris FrancisSVP, Corporate Development, Head of Emerging AreasSale208.8K$13.67$2.9M
Oct 19, 2024Paul BolnoPresident and CEOSale90.5K$15.00$1.4M
Oct 1, 2024GSK plc10% OwnerPurchase2.8M$8.00$22.3M
Sep 28, 2024Kyle MoranChief Financial OfficerSale17.1K$9.00$154.3K

Showing the 25 most recent of 78 Form 4 filings for Wave Life Sciences Ltd..

Most active WVE insiders

  • Paul Bolno19 filings
  • Chris Francis14 filings
  • Chandra Vargeese9 filings
  • Kyle Moran8 filings
  • Michael A. Panzara7 filings

Ask anything about WVE insider activity

Use Trabud's AI agent to query Wave Life Sciences Ltd.'s Form 4 history in plain English — "Show me WVE CEO purchases this year" or compare it against any other ticker.

Open the AI agent

WVE insider trading FAQ

Are Wave Life Sciences Ltd. insiders buying or selling?

Across 78 SEC Form 4 filings, Wave Life Sciences Ltd. (WVE) insiders reported 8 open-market purchases totaling $133.8M and 70 sales totaling $29.6M. That is a net buying position of $104.2M.

How many insiders trade WVE stock?

14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Wave Life Sciences Ltd.. The most recent filing was accepted on Mar 31, 2026.

Where does Trabud get WVE insider trading data?

All WVE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content